Symbyax™ (a combination of the ingredients of Prozac and Zyprexa ) has been approved for the for the treatment of depressive episodes associated with bipolar disorder.

AstraZeneca's Seroquel has been approved for the treatment of acute mania associated with bipolar disorder. The drug was first approved to treat schizophrenia in adults in 1997.

Jansen's antipsychotic Risperdal has been approved for the treatment of bipolar mania.

Lexapro, a selective serotonin reuptake inhibitor (SSRI), has been approved for the treatment of generalized anxiety disorder (GAD), a condition that affects approximately four million Americans annually.